Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Faron Pharmaceuticals
Faron Pharmaceuticals
Activities:
Research & Development
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Regulatory
New patent protects the intravenous use of interferon-beta in a novel formulation
Faron has developed the first intravenous formulation of IFN-beta to enable the treatment of vascular leakage in lungs and other central organs
Manufacturing
Abzena to manufacture therapeutic antibody for Faron
Clevegen is a novel therapeutic antibody being developed by Faron to reduce immune suppression in cancer
Research & Development
Faron strengthens executive team by appointing new Medical Director
He will play a central role in expanding the Finnish firm's clinical programmes of drug candidates
Research & Development
Faron links up with Selexis to progress development of cancer antibody
Under the agreement, Faron will have access to the Selexis SUREtechnology platform and SURE CHO-M cell line
Ingredients
Rentschler to manufacture Traumakine for Faron
German contract manufacturer first produced product in 1980s
Subscribe now